🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of rapid British shipping. Sellers promote the substance there before redirecting customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering products of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking penalties, legal action or prison.

Service Response and Content Removal

Based on TikTok, the service has taken down violative material and prohibited related keywords and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Research also discovered communities with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, filled with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at home.

Within moments of joining one group, a seller posted WhatsApp details, where most transactions take place. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Details and Costs

Inside these groups, posts display black plastic packages with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how long a pen should last, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Even if the research behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject patients to possibly serious health risks”.